期刊文献+

多囊卵巢综合征患者子宫内膜胰岛素抵抗的分子机制 被引量:5

Molecular Mechanisms of Insulin Resistance in Endometrium of Patients with PCOS
下载PDF
导出
摘要 目的研究多囊卵巢综合征(PCOS)患者子宫内膜胰岛素受体底物1(IRS-1)、底物2(IRS-2)蛋白表达及酪氨酸磷酸化的程度,探讨PCOS患者子宫内膜胰岛素抵抗(IR)的分子机制。方法采用放射免疫法检测PCOS合并IR患者15例(PCOS IR组)、PCOS非IR患者15例(PCOS非IR组)和正常妇女10例(对照组)的血清黄体生成素(LH)、卵泡刺激素(FSH)、睾酮及空腹血清胰岛素(FIN)水平;利用稳态模型(HOMA)计算胰岛素抵抗指数(HOMA-IR);采用蛋白印迹法(Western blot)检测子宫内膜IRS-1和IRS-2的蛋白表达;采用免疫沉淀法检测IRS-1和IRS-2酪氨酸磷酸化程度,并进行分析比较。结果①PCOS合并IR组患者血清LH[(15.2±2.6)U/L]、LH/FSH[(2.4±0.4)]及睾酮[(2.6±0.3)nmol/L]均明显高于对照组[分别为(5.8±2.5)U/L,(0.8±0.3),(1.0±0.2)nmol/L],差异均有统计学意义(均P<0.05);PCOS合并IR组FIN[(13.8±3.1)μU/mL]、HOMA-IR(3.2±1.4)均明显高于PCOS非IR组[(6.4±3.8)μU/mL,(1.7±0.8)]及对照组[(6.5±1.9)μU/mL,(1.6±0.8)],差异均有统计学意义(均P<0.05);②PCOS合并IR组IRS-1和IRS-2蛋白表达均明显低于PCOS非IR组和对照组(均P<0.01);PCOS非IR组与对照组比较差异无统计学意义(均P>0.05);③PCOS合并IR组IRS-1和IRS-2蛋白酪氨酸磷酸化程度均明显低于PCOS非IR组和对照组(均P<0.01);PCOS非IR组与对照组比较差异无统计学意义(均P>0.05)。结论 PCOS合并IR患者子宫内膜组织的IRS-1和IRS-2蛋白表达及酪氨酸磷酸化程度降低导致受体后信号转导障碍,可能参与了PCOS子宫内膜IR的发生。 Objective To investigate the tyrosine phosphorylation and protein expression of insulin receptor substrate 1 and 2(IRS-I,IRS-2)in endometrium from patients with polycystic ovary syndrome(PCOS), and explore the molecular mechanisms of insulin resistance(IR)in endometrium of patients with PCOS. Methods Serum and endometrium samples from patients with PCOS with IR(n=15),PCOS without IR(n= 15)and controls(n= 10)were collected. Serum luteinizing hormone(LH),follicle stimulating hormone(FSH), testosterone(T)and fasting insulin(FIN)were measured by radioimmunoassay. Fasting plasma glucose(FPG)was measured by oxidase assay. IR index was calculated using homeostasis model assessment(HOMA). The expression of IRS-1 and IR-2 was assessed by Western blot. The tyrosine phosphorylation was measured by immunoprecipitation. Results ①The serum levels of LH, LH/FSH and T in PCOS with IR were significantly higher than those in control group (all P〈0.05). There was no significant difference between PCOS with IR and PCOS without IR(all P〉0. 05). The serum FIN and HOMA IR in PCOS with IR were significantly higher than those in PCOS without IR and control group(all P〈0.05). There was no significant difference between PCOS without IR and control group(all P〉0. 05);②The protein expression of IRS-1 and IRS2 in PCOS with IR was significantly decreased compared to that in PCOS without IR and controls(all P〈0.01 ). There was no significant difference between PCOS without IR and controls(all P〉0. 05)③The tyrosine phosphorylation of IRS-1 and IRS-2 in PCOS with IR was significantly decreased compared to that in PCOS without IR and controls(all P〈0. 01). There was no significant difference between PCOS without IR and controls(all P〉0. 05). Conclusion The signal transduction malfunction because of protein expression and tyrosine phosphorylation of IRS in endometrium may be one of mechanisms leading to IR in endometrium from patients with PCOS.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2010年第4期457-460,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No.30750007)
关键词 多囊卵巢综合征 子宫内膜 酪氨酸磷酸化 胰岛素抵抗 polycystic ovary syndrome endometrium tyrosine phosphorylation insulin resistance
  • 相关文献

参考文献15

  • 1IaIatrakis G,Tsionis C,Adonakis G,et al.Polycystic ovarian syndrome,insulin resistance and thickness of the endometrium[J].Eur J Obstet Gynecol Reprod Biol,2006,127(2):218-221.
  • 2RutanenE-Ml.Insulin-like growth factor in endometrial function[J].Gynecol Endocrinol,1998,12(3):399-406.
  • 3初永丽,孙永玉,邱红玉,李红发.胰岛素受体底物1蛋白表达及其酪氨酸磷酸化程度与多囊卵巢综合征发病的关系[J].中华妇产科杂志,2004,39(3):176-179. 被引量:15
  • 4邱红玉,初永丽,李旻,孙永玉,李红发.多囊卵巢综合征合并胰岛素抵抗患者脂肪组织胰岛素受体底物2蛋白的表达及酪氨酸磷酸化的研究[J].中华妇产科杂志,2005,40(2):116-119. 被引量:12
  • 5Wu X K,Zhou S Y,Liu J X,et al.Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome[J].Fertil Steril,2003,80(4):954-965.
  • 6Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Wo-rkshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J].Fertil Steril,2004,81(1):19-25.
  • 7Strowitzki T,Capp E,von Wolff M,et al.Expression of glucose transporter 1 in human endometrial and decidual tissue[J].Gynecol Endocrinol,2001,15(2):219-224.
  • 8Ioni R,Chiarelli S,Xamin N,et al.Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients[J].J Clin Endocrinol,2004,89(10):4089-4096.
  • 9Mozzanega B,Minoni R,Granzotto M,et al.Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome[J].Ann N Y Acda Sci,2004,1034(2):364-374.
  • 10Shulman G I.Cellular mechanisms of insulin resistance[J].J Clin Invest,2000,106(2):171-176.

二级参考文献34

  • 1罗盛康,席菁乐.成人前脂肪细胞的原代培养[J].第一军医大学学报,2005,25(3):270-273. 被引量:12
  • 2TILG H, MOSCHEN A R. Inflammatory mechanisms in the regulation of insulin resistance[J]. Mol Med, 2008,14(3/4) : 222-231.
  • 3CHARO I F, RANSOHOFF R M. The many roles of chemokines and ehemokine receptors in inflammation[J]. N Engl J Med, 2006, 354(6) :610-621.
  • 4BAJETTO A, BONAVIA R, BARBERO S, et al. Chemokines and their receptors in the central nervous system[J]. Front Neuroendocrinol,2001,22(3) : 147-184.
  • 5JUAREZ J, BENDALL L, BRADSTOCK K. Chemokines and their receptors as therapeutic targets: the role of the SDF-1/CX- CR4 axis[J].Curr Pharm Des,2004,10(11) : 1245-1259.
  • 6KANTELE J M, KURK S, JUTILA M A, et al. Effects of continuous exposure of stromal cell-derived factor-1 alpha on T cell rolling and tight adhesion to monolayers of activated endothelial cells[J].J Immunol, 2000,164(10): 5035-5040.
  • 7MARTIN K, SALAM M A, AKHTER J, et al. Role of stromal-cell derived factor-1 in the development of autoimmune diseases in non-obese diabetic mice[J]. Immunology, 2002,107(2) : 222-232.
  • 8LENG Q, NIE Y, ZOU Y, et al. Elevated CXCL12 expression in the bone marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development [J]. BMC Immunol, 2008, 9(1) :51.
  • 9MENDES-DA-CRUZ D A, SMANIOTTO S, KELLER A C, et al. Multivectorial abnormal cell migration in the NOD mouse thymus[J]. J Immunol,2008,180(7):4639-4647.
  • 10ABOUMRAD E, MADEC A M, THIVOLET C. The CX- CR4/CXCL12 (SDF-1) signaling pathway protects non-obese diabetic mouse from autoimmune diabetes[J]. Clin Exp Immunol, 2007, 148(3):432-439.

共引文献31

同被引文献92

  • 1姜荣华,徐望明,杨菁.达英-35联合罗格列酮对多囊卵巢综合征胰岛素抵抗患者的临床疗效[J].生殖医学杂志,2005,14(2):108-110. 被引量:5
  • 2程庆丰,李卫平,李启富.胰岛素抵抗和多囊卵巢综合征[J].中国糖尿病杂志,2007,15(2):117-119. 被引量:10
  • 3林金芳,李昕,苏椿淋.多囊卵巢综合征患者胰岛素抵抗的诊断方法及治疗策略[J].中国实用妇科与产科杂志,2007,23(9):663-667. 被引量:71
  • 4Ovalle F,Azziz R. Insulin resistance,polycystic ovary syndrome,and type 2 diabetes mellitus[J].Fertility and Sterility,2002,(06):1095-1105.
  • 5Moran L J,Misso M L,Wild R A. Impaired glucose tolerance,type 2 diabetes and metabolic syndrome in polycystic ovary syndrome:a systematic review and meta-analysis[J].Human Reproduction Update,2010,(04):347-363.
  • 6Farrell K,Antoni M H. Insulin resistance,obesity,inflammation,and depression in polycystic ovary syndrome:biobehavioral mechanisms and interventions[J].Fertility and Sterility,2010,(05):1565-1574.
  • 7Yang Z H,Peng X D. Insulin resistance and heart injury in rats with insulin resistance or type 2 diabetes mellitus[J].Acta Cardiologica,2010,(03):329-335.
  • 8Basyi git F,Temizhan A,Malcok O. The relationship between insulin resistance and left ventricular systolic and diastolic functions and functional capacity in patients with chronic heart failure and metabolic syndrome[J].Turk Kardiyol Dern Ars,2010,(03):173-181.
  • 9Waterworth D M,Bennett S T,Gharani N. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome[J].The Lancet,1997,(9057):986-990.
  • 10Siegel S,Futterweit W,Davies T F. A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome[J].Fertility and Sterility,2002,(06):1240-1243.

引证文献5

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部